# POTASSIUM PHOSPHATES

NDC: 70121-1722
Generic name: Potassium Phosphates in sodium chloride
Labeler / Manufacturer: Amneal Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20240730

FDA application: NDA218343

## Active ingredients

- POTASSIUM PHOSPHATE, DIBASIC: 4.72 mg/mL
- POTASSIUM PHOSPHATE, MONOBASIC: 4.48 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70121-1722"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70121-1722
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dce22c93-aa48-48a9-ac8b-716400d33c9e